SMAD3 and cervical carcinoma: Different studies found an increased expression of miR‐142‐5p in cervical cancers in comparison to normal cervical tissues that favored cervical cancer progression by targeting Wnt/β‐catenin pathway [38] and SMAD3, a negative regulator of TGF‐β signaling [39].